Amgen, founded in California in 1980, is a leading producer of biotechnological, protein-based medicines, targeted at combating grievous illnesses. The global biopharmaceutical company had only a few dozen employees when it started up in Breda in 1997. It has grown to well over 500 since that time, with approximately 17,000 staff members worldwide. What began as Amgen’s European Logistics Center has now developed into a campus that is home to five Amgen operations.
When Amgen was looking for a location for its European distribution center, it selected Breda in Brabant. “There were various motives at the time for this choice. Generally speaking, it was the favorable labor climate of the Netherlands, which also boasts a large English-speaking population. Additional benefits of Brabant and Breda included logistics, such as excellent infrastructure and the proximity of major international carriers, its location between the ports of Rotterdam and Antwerp, and the proximity of various major airports such as Amsterdam, Brussels, Cologne and Dusseldorf,” said Jan Bouman, Executive Director Site Operations and Site Leader at Amgen Breda.
These favorable location factors still apply some 15 years after the launch. The number of countries that Amgen serves from Breda has grown quickly in recent years, and will grow even further in the coming years. Its drugs are shipped from Breda to countries in Europe, the Middle East, South-America, Australia and Africa. Its logistics activities include distribution, assembly, design, packaging and labeling. Amgen Breda’s headquarters has also become one of the company’s most important locations in the world.